HEALTH STATUS IN KIDNEY REPLACEMENT THERAPY: A SUBGROUP ANALYSIS OF THE CONVINCE RANDOMIZED CONTROLLED TRIAL

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/8e58ee26653f58bae05e9e7dc3fae0a8.pdf
HEALTH STATUS IN KIDNEY REPLACEMENT THERAPY: A SUBGROUP ANALYSIS OF THE CONVINCE RANDOMIZED CONTROLLED TRIAL

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Krister
Cromm
Krister Cromm krister.cromm@freseniusmedicalcare.com Fresenius Medical Care Global Medical Office Bad Homburg Germany * Charite Center for Patient-Centered Outcomes Research Berlin Germany
Ngoc Pham ngoc.pham@freseniusmedicalcare.com Fresenius Medical Care Global Medical Office Bad Homburg Germany - Charite Center for Patient-Centered Outcomes Research Berlin Germany
Giovanni Strippoli gfmstrippoli@gmail.com University of Bari Department of Precision and Regenerative Medicine and Ionian Area (Dimepre-J) Bari Italy - University of Sydney School of Public Health Sydney Australia
Claudia M. Barth claudia.barth@bbraun.com B Braun Avitum AG Melsungen Germany -
Bernard J. Canaud canaudbernard@gmail.com University of Montpellier Montpollier France -
Andrew Davenport andrewdavenport@nhs.net University College London London United Kingdom -
Jörgen B. Hegbrant jbahegbrant@gmail.com Lund University Lund Sweden -
Mark Woodward markw@georgeinstitute.org.au The George Institute for Global Health UK Oxford United Kingdom - The George Institute for Global Health Australia Sydney Australia
Michiel L. Bots M.L.Bots@umcutrecht.nl University of Utrecht Universitair Medisch Centrum Utrecht, Utrecht Utrecht Netherlands -
Peter J. Blankestijn P.J.Blankestijn@umcutrecht.nl University of Utrecht Universitair Medisch Centrum Utrecht, Utrecht Utrecht Netherlands -
Felix Fischer felix.fischer@charite.de Charite Center for Patient-Centered Outcomes Research Berlin Germany -
Matthias Rose matthias.rose@charite.de Charite Center for Patient-Centered Outcomes Research Berlin Germany -
-
-
-